CD&R will pay 10.23 pounds in cash per share in UDG, representing a premium of 21.5% to Tuesday's close. By 0735 GMT the London-listed shares were up 22.2% at 10.30 pounds.

Brendan McAtamney has stepped down from his role as chief executive of UDG Healthcare following the completion of a deal to acquire the company by Clayton Dublier and Rice for €3.2 billion.

(Reuters) -UDG Healthcare said on Tuesday private equity firm Clayton, Dubilier & Rice (CD&R) has raised its offer to buy the London-listed firm to 2.76 billion pounds ($3.83 billion). UDG said ...

Brendan McAtamney is to step down from his role as chief executive of UDG Healthcare with immediate effect. This follows the conclusion of the acquisition of UDG Healthcare by Clayton Dublier ...

A specialist in rare disease drug launches, Cambridge BioMarketing has been snapped up by an Irish healthcare service provider UDG Healthcare in a $35 million deal. Buying the Massachusetts-based ...